0RH2 Stock Overview
Engages in the research and development, planning, manufacture, and sale of laser systems in Italy, rest of Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
EL.En. S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €11.44 |
| 52 Week High | €11.91 |
| 52 Week Low | €8.29 |
| Beta | 1.59 |
| 11 Month Change | 6.91% |
| 3 Month Change | 20.69% |
| 1 Year Change | 15.91% |
| 33 Year Change | -28.77% |
| 5 Year Change | 46.20% |
| Change since IPO | 483.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0RH2 | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 14.3% | 6.6% | -1.8% |
| 1Y | 15.9% | 0.6% | 5.8% |
Return vs Industry: 0RH2 exceeded the UK Medical Equipment industry which returned -4.5% over the past year.
Return vs Market: 0RH2 exceeded the UK Market which returned 7.9% over the past year.
Price Volatility
| 0RH2 volatility | |
|---|---|
| 0RH2 Average Weekly Movement | 7.1% |
| Medical Equipment Industry Average Movement | 6.0% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.0% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0RH2's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: 0RH2's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1981 | 2,030 | n/a | elengroup.com |
EL.En. S.p.A. engages in the research and development, planning, manufacture, and sale of laser systems in Italy, rest of Europe, and internationally. The company offers medical laser equipment for use in the fields of physiotherapy, orthopedics, traumatology, rheumatology, dermatology, sports and rehabilitative medicines, surgery, aesthetics, and art; EchoLaser, an integrated laser-ultrasound system that allows diagnosis and treatment of benign and malignant lesions; hair removal and non-invasive body contouring products; and laser sources and systems for cutting, welding, marking, and engraving on countless materials.
EL.En. S.p.A. Fundamentals Summary
| 0RH2 fundamental statistics | |
|---|---|
| Market cap | €912.78m |
| Earnings (TTM) | €49.76m |
| Revenue (TTM) | €659.63m |
18.3x
P/E Ratio1.4x
P/S RatioIs 0RH2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0RH2 income statement (TTM) | |
|---|---|
| Revenue | €659.63m |
| Cost of Revenue | €412.27m |
| Gross Profit | €247.35m |
| Other Expenses | €197.59m |
| Earnings | €49.76m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 14, 2024
| Earnings per share (EPS) | 0.62 |
| Gross Margin | 37.50% |
| Net Profit Margin | 7.54% |
| Debt/Equity Ratio | 19.1% |
How did 0RH2 perform over the long term?
See historical performance and comparison